Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside G(M3): Involvement of receptor-directed protein tyrosine phosphatase(s)

British Journal of Cancer

Volumn 75, Issue 2, 1997, Pages 213-220

  Suarez Pestana, E ^a   Greiser, U ^b   Sanchez B ^a   Fernandez L E ^a   Lage, A ^a   Perez, R ^a   Bohmer F D ^b  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Epidermal growth factor receptor; Ganglioside G(M3); Growth inhibition; Monoclonal antibody; Protein tyrosine phosphatases

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE GM3; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; RECEPTOR ANTIBODY;

ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG POTENTIATION; ENZYME REGULATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

EID: 0000470849     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.36     Document Type: Article

References (59)

1. Barnes DW (1982) Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum free cell culture. J Cell Biol 93: 1-4
2. Baselga J and Mendelsohn J (1944a) The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat 29: 127-138
3. Baselga J and Mendelsohn J (1994b) Receptor blockade with monoclonal antibodies as anti-cancer therapy. Pharmacol Ther 64: 127-154
4. Bergh J, Larsson E, Nilsson K and Zech L (1982) Establishment and characterization of two neoplastic cell lines (U-1285 and U-1568) derived from small cell carcinoma of the lung. Acta Pathol Microbiol Immunol Scand A 90: 149-158
5. Bergh J, Nilsson K, Zech L and Glovanella P (1981) Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752). Anticancer Res 1: 317-322
6. Bergh J, Nilsson K, Ekman R and Giovanella B (1985) Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand A 93: 133-147
7. Böhmer FD, Böhmer, SA and Heldin, CH (1993) The dephosphorylation characteristics of the receptors for epidermal growth factor and platelet-derived growth factor in Swiss 3T3-cell membranes suggest differential regulation of receptor signalling by endogenous protein-tyrosine phosphatases. FEBS Lett 331: 276-280
8. Böhmer FD, Böhmer A, Obermeier A and Ullrich A (1995) Use of selective tyrosine kinase blockers to monitor growth factor receptor dephosphorylation in intact cells. Anal Biochem 228: 267-273
9. M4 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 261: 2434-2440
10. Carney DN, Gazdar AF, Bepler G, Guccion GJ, Marangos PJ, Moody TW, Zweing MH and Minna JD (1985) Establishment and identification of small cell cancer cell line having classic and variant features. Cancer Res 45: 2913-2923
11. Charbonneau, H and Tonks NK (1992) 1002 phosphatases? Annu Rev Cell Biol 8: 463-493
12. Cohen S and Carpenter G (1975) Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci USA 72: 1317-1321
13. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS and Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712
14. Di Fiore P, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J and Aaronson SA (1987) Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51: 1063-1070
15. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J and Waterfield MD (1984) Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307: 521-527
16. Faure R, Baquiran G, Bergeron JJM and Posner BI (1992) The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatases. J Biol Chem 267: 11215-11221
17. Fernandez A, Spitzer E, Perez R, Boehmer FD, Eckert K, Zschiesche W and Grosse R (1992) A new monoclonal antibody for detection of EGF-receptors in Western blots and paraffin-embedded tissue sections. J Cell Biochem 49: 157-165
18. Fong CJ, Sherwood ER, Mendelsohn J, Lee C and Kozlowski JM (1992) Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor-alpha. Cancer Res 52: 5887-5892
19. Fonseca R, Lombardero J, Perez R, Quintero S, Tormo B, Macias A, Rios M, Cordies N, Fony F, Leon B, Puig M, Aguilar O, Rodriguez C and Lage A (1988) Effecto antitumoral del factor de crecimiento epidermico en carcinoma de piel humano. Interferon Biotecnologia 5: 270-277
20. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi H, Angeletti CA, Pingitore R, Pepe S, Basolo F and Bevilacqua G (1995) Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer 31A: 178-183
21. Fry DW, Kraker AJ, Mcmichael A, Ambroso LA, Nelson JM, Leopold WR, Conners RW and Bridges AJ (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265: 1093-1095
22. Gazdar AF, Carney DN, Russel EK, Smis HL, Bylin SB, Bunn JR, Guccion GJ and Minna AJD (1980) Establishment of continous clonable culture of small cell carcinoma of the lung which have amino precursor uptake and decarboxylation cell properties. Cancer Res 40: 3502-3507
23. Gibbs JB and Oliff A (1994) Pharmaceutical research in molecular oncology. Cell 79: 193-198
24. Groenen LC, Nice EC, and Burgess AW (1994) Structure-function relationships for the EGF/TGFα family of mitogens. Growth Factors 11: 235-257
25. Hakomori S (1993) Structure and function of sphingoglycolipids in transmembrane signalling and cell cell interactions. Biochem Soc Trans 21: 583-595
26. M3 in tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 263: 10915-10921
27. Hashimoto N, Zhang WR and Goldstein BJ (1992) Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system. Biochem J 284: 569-576
28. Hayman MJ, Kitchener G, Vogt PK and Beug H (1985) The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity. Proc Natl Acad Sci USA 82: 8237-8241
29. Kamata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S and Kuroki T (1986) Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res 46: 1648-1653
30. Khazaie K, Schirrmacher V and Lichtner RB (1993) EGF receptor in neoplasia and metastasis. Cancer Metas Rev 12: 255-274
31. Klijn JGM, Berns PMJJ, Schmitz PIM and Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: a review on 5232 patients. Endocrine Rev 13: 3-17
32. Lammers R, Bossenmaier B, Cool DE, Tonks NK, Schlessinger J, Fischer EH and Ullrich A (1993) Differential activities of protein tyrosine phosphatases in intact cells. J Biol Chem 268: 22456-22462
33. Levitzki A and Gazit A (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267: 1782-1788
34. Lombardero J, Perez R and Lage A (1986) Epidermal growth factor inhibits thymidine incorporation in Ehrilich ascites tumor cells in vivo. Neoplasma 33: 423-429
35. Macias A, Azavedo E, Perez R, Rutqvist LE and Skoog L (1986) Receptors for epidermal growth factor in human mammary carcinomas and their metastases. Anticancer Res 6: 849-851
36. Macias A, Azavedo E, Hagerstrom T, Klintenberg C, Perez R and Skoog L (1987a) Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res 7: 459-464
37. Macias A, Perez R, Hagerstrom T and Skoog L (1987b) Identification of transforming growth factor alpha in human primary breast carcinomas. Anticancer Res 7: 1271-1275
38. Modjtahedi H and Dean C (1994) The receptor for EGF and its ligands - expression, prognostic value and target for therapy in cancer (review ). Int J Oncol 4: 277-296
39. Modjtahedi H, Eccles S, Box G, Styles J and Dean C (1993) Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor - receptor interaction. Br J Cancer 67: 254-261
40. Mueller H, Romerdahl CA, Trent JM and Reisfeld RA (1991) Suppression of spontaneous melanoma metastasis in SCID mice with an antibody to the epidermal growth factor receptor. Cancer Res 51: 2193-2198
41. Nores GA, Hanai N, Levery SB, Eaton HL, Salyan ME and Hakomori S (1989) Synthesis and characterization of ganglioside GM3 derivatives: lyso-GM3, de-N-acetyl-GM3, and other compounds. Methods Enzymol 179: 242-253
42. Osherov N and Levitzki A (1994) Epidermal-growth-factor-dependent activation of the Src-family kinases. Eur J Biochem 225: 1047-1053
43. Perez R, Pascual M, Macias A and Lage A (1984) Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 4: 189-193
44. Pot DA and Dixon JE (1992) A 1000 and 2 protein tyrosine phosphatases. Biochim Biophys Acta 1136: 35-43
45. Pumiglia KM, Lau LF, Huang CK, Burroughs S and Feinstein, MB (1992) Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Biochem J 286: 441-449
46. Reins HA, Steinhilber G, Freiberg B and Anderer FA (1993) Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction. J Cell Biochem 51: 236-248
47. Rodeck U, Herlyn M, Herlyn D, Molthoff C, Atkinson B, Varello M, Steplewski, Z and Koprowski, H (1987) Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. Cancer Res 47: 3692-3696
48. Sainsbury JR, Farndon JR, Sherbet GV and Harris AL (1985) Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1: 364-366
49. Scatchard G (1949) The attraction of protein for small molecules and ions. Ann N Y Acad Sci 5: 660-665
50. Söderdahl G, Betzholz C, Johansson A, Nilsson K and Bergh J (1988) Differential expression of platelet-derived growth factor and transforming growth factor genes in small-and non-small-cell human lung carcinoma lines. Int J Cancer 41: 636-641
51. Svennerholm L (1973) Gangliosides, isolation. Methods Carbohydr Chem 6: 430-603
52. Svennerholm L (1994) Gangliosides - a new therapeutic agent against stroke and Alzheimer's disease. Life Sci 55: 2125-2134
53. Swarup G, Cohen S and Garbers DL (1982) Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Comm 107: 1104-1109
54. Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E, Ullrich A and Böhmer FD (1995) Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTPIC. J Biol Chem 270: 21277-21284
55. Ullrich A, and Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212
56. Velu TJ, Beguinot L, Vass WC, Willingham MC, Merlino GT, Pastan I and Lowy, DR (1987) Epidermal-growth-factor-dependent transformation by a human EGF receptor protooncogene. Science 238: 1408-1410
57. Weis FM and Davis RJ (1990) Regulation of epidermal growth factor receptor signal transduction. Role of gangliosides. J Biol Chem 265: 12059-12066
58. Yoneda T, Lyall RM, Alsina MM, Persons PE, Spada AP, Levitzki A, Zilberstein A and Mundy GR (1991) The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vivo and in nude mice. Cancer Res 51: 4430-4435
59. Zhou QG Hakomori S Kitamura K and Igarashi Y (1994) G(M3) directly inhibits tyrosine phosphorylation and de-N-acetyl-G(M3) directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J Biol Chem 269: 1959-1965